Optimising intravenous salbutamol in children: a phase 2 study
Sign Up to like & getrecommendations! Published in 2022 at "Archives of Disease in Childhood"
DOI: 10.1136/archdischild-2022-324008
Abstract: Objective The β2-agonists such as salbutamol are the mainstay of asthma management. Pharmacokinetic–pharmacodynamic (PKPD) models to guide paediatric dosing are lacking. We explored the relationship between salbutamol dose, serum concentration, effectiveness and adverse effects in… read more here.
Keywords: children phase; optimising intravenous; intravenous salbutamol; salbutamol ... See more keywords